AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
An international team of researchers led by Lancaster University have made a promising breakthrough in the development of ...
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...
In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer's ...
(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and ...